Because the global mortality rate for TB has fallen, it is easy to declare victory against a bacillus that continues to lie dormant in millions of healthy individuals. In addition, drug-resistant strains wreak havoc in resource-poor settings and, as we found out with other pathogens, microbes do not respect borders. Here is a quick update on some of the facts, current treatment strategies, and what is new in the field.
